Pyridoxamine 5’-phosphate oxidase deficiency : a potentially treatable epileptic encephalopathy

Joint Authors

al-Mutawi, Latifah
Khalil, Ayman

Source

Journal of the Bahrain Medical Society

Issue

Vol. 34, Issue 3 (30 Sep. 2022), pp.52-56, 5 p.

Publisher

Bahrain Medical Society

Publication Date

2022-09-30

Country of Publication

Bahrain

No. of Pages

5

Main Subjects

Medicine

Abstract EN

Pyridoxal phosphate-responsive neonatal epileptic encephalopathy due to pyridoxamine-5-prime-phosphate oxidase deficiency is a rare cause of epileptic encephalopathy.

a neonate with this condition presents early in life with refractory seizures which does not respond to conventional anti-epileptic medications, depressed level of consciousness, and severe psychomotor retardation if left untreated.

early initiation of active cofactor pyridoxal-5’-phophate can be curative.

we are describing a rare neurometabolic condition; the first case in the kingdom of bahrain to the best of our knowledge.

American Psychological Association (APA)

al-Mutawi, Latifah& Khalil, Ayman. 2022. Pyridoxamine 5’-phosphate oxidase deficiency : a potentially treatable epileptic encephalopathy. Journal of the Bahrain Medical Society،Vol. 34, no. 3, pp.52-56.
https://search.emarefa.net/detail/BIM-1499955

Modern Language Association (MLA)

al-Mutawi, Latifah& Khalil, Ayman. Pyridoxamine 5’-phosphate oxidase deficiency : a potentially treatable epileptic encephalopathy. Journal of the Bahrain Medical Society Vol. 34, no. 3 (2022), pp.52-56.
https://search.emarefa.net/detail/BIM-1499955

American Medical Association (AMA)

al-Mutawi, Latifah& Khalil, Ayman. Pyridoxamine 5’-phosphate oxidase deficiency : a potentially treatable epileptic encephalopathy. Journal of the Bahrain Medical Society. 2022. Vol. 34, no. 3, pp.52-56.
https://search.emarefa.net/detail/BIM-1499955

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references : p. 56

Record ID

BIM-1499955